DAFTAR PUSTAKA

1. Libby P. The vascular biology of atherosclerosis. http://www.harcourthealth.com/SIMON/Braunwald/
chapter30.pdf. Dec 22, 2000
2. Sloop GD, Kevin JW, Ira Tabas, Peter LW, Martin RB. Atherosclerosis-an inflammatory disease. NEJM 1999 June 17 Volume 340 Number 24; 1928-29
3. Constantinides P. The commonest causes of anoxic necrosis. Dalam: General pathobiology. Norwalk, Connecticut: Appleton & Lange; 1994. 59-116
4. Ross R. Atherosclerosis-an inflamatory disease. NEJM 1999 January 14 Volume 340 Number 2; 115-26
5. Freestone T, Turner RJ, Higman DJ, Lever MJ, Powell JT. Influence of hypercholesterolemia and adventitial inflamation on the development of aortic aneurysm in rabbits. Arteriosclerosis, thrombosis and vascular biology 1997; 17:10-17
6. Shih DM, Welch, C, Lusis AJ. New insights into atherosclerosis from studies with mouse models. Mol-Med- Today 1995 Nov; 1(8): 364-72
7. Smith R. Animal research: the need for a middle ground. Let's promote the three Rs of animal research: replacement, reduction & refinement. BMJ 2001 Feb, 3: 7281; 248-249
8. Mitchell RN, Ramzi S, Cotran. Cell injury and adaptation. In: Basic pathology. 6th ed. Philadelphia: WB Saunders co; 1997. 1-25
9. Everson SA, John W. Lynch, Margareth A. Chesney, George A. Kaplan, Debie E. Goldbe et al. Interaction of workplace demands and cardiovascular reactivity in progression of carotid atherosclerosis: population based study. BMJ 1997 February 22: 314; 553
10. Stary HC. et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on atherosclerosis.AHA. http://www.americanheart.org/
Scientific/statements/1994/059401/html. Dec 22, 2000
11. Tuveri M. Pathophysiological aspects of vascular disease, role of hemodynamic factors. Biomedical application group. METDST 1999 September 2; 18:51:14
12. Potnios AV, Severina D'Mello. Essential hypertension. A review.http://www.bhj.org/journal/1996/3801_jan/
reviews_127.htm. Dec 22, 2000
13. Gurr MI. Role of fats in food and nutrition. 2nd ed. New York: Elseiver Science Publisher Ltd; 1992. 7-51; 79-95.
14. Kumar V, Cotran RS, Robbins SL. Blood and vessels. Dalam: Basic pathology. 6th ed. Philadelphia: WB. Saunders co; 1997. 281-307.
15. Underwood JCE. Sistem kardiovaskuler. Dalam: Patologi umum dan sistematik. Edisi bahasa Indonesia. Sarjadi, editor. Jakarta: EGC; 2000. 323-78.
16. Stary HC. et al. A definition of advanced types of atherosclerotic lesions&histological classification of athero- sclerosis. AHA. Art.Scler.Thr. Vasc Biol 1995;15:1512-31
17. Carr C. Sandra, Vasana Cheanvechai. Histology and clinical significance of the carotid atherosclerotic plaque: Implications for endovascular treatment. Journal of Endovascular Therapy Vol 4 No. 4. pp. 321-25
18. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan AIJM Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 1998 Jan 6-13. 97(1):99-107
19. Graves DT, Yanling Jiang, Anthony JV The expression of MCP-1 and other chemokines by osteoblast. Frontriers in Bioscience 4 1999 July 1. 571-80
20. Shimokawa H. Clinical assessment of endothelial function. http://www. j-circ.or.jp/english/sessions/reports/64th- ss/shimokawa.htm Dec 22, 2000
21. Stinga EV, Knauper G, Murphy J. Gavrilovic. Collagen degradation and PDGF stimulate the migration of VSMC. J.Cell Sci 2000 113 : 2055-64
22. Grainger DJ, JC Metcalfe, AA Grace, DE Mosedale. TGF-beta dynamically regulates vascular smooth muscle differentiation in vivo. J.Cell Sci. 2000. 111. 2977-88
23. Sanz-Gonzales SM, Enric Poch, R Ignacio Perez, J Antonio Diez. Control of VSMC growth by cyclin-kinase inhibitory proteins and its implication in cardiovascular. Frontiers in Bioscience 5 2000 July. 619-28
24. Kuivenhoven JA, J Wouter J, Aeilko H Zwinderman, Peter de Kniff, Ruth McPherson, Albert VG Bruschke, Kong I Lie, John JP Kastelein. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. NEJM 1998 Jan 8 Vol. 338:86-93
25. Rader DJ. Research summary. http://health.upenn.edu/~CET/rader.htm Dec 22, 2000
26. Panza JA. High-normal blood pressure-more ”high” than “normal”. NEJM 2001 November 1 Volume 345. Number 18:37-1339
27. Aikawa M. Lipid lowering as an anti-inflammatory therapy on vulnerable atherosclerotic plaques. Webmaster@j- circ.or.jp Jan 12, 2002

<<Previous Page

Berdiri tahun 2005, dipublikasi oleh: Tim Karya Tulis Ilmiah Mahasiswa Fakultas Kedokteran Universitas Diponegoro Semarang